You have 9 free searches left this month | for more free features.

Secondary hyperoxaluria

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Secondary Hyperoxaluria, Nephrolithiasis, Hyperoxaluria Trial in United States (Test Meal)

Completed
  • Secondary Hyperoxaluria
  • +3 more
  • Test Meal
  • Tucson, Arizona
  • +4 more
Oct 5, 2021

Secondary Hyperoxaluria, Nephrolithiasis Trial in Brussels (Lanthanum Carbonate)

Recruiting
  • Secondary Hyperoxaluria
  • Nephrolithiasis
  • Lanthanum Carbonate
  • Brussels, Belgium
    University Hospital Brussels
Jan 7, 2021

Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

Recruiting
  • Adenine Phosphoribosyltransferase Deficiency
  • +83 more
    • Bristol, South West, United Kingdom
      Zoe Plummer
    Sep 26, 2023

    Healthy Volunteers, Enteric Hyperoxaluria Trial in Canada, United States (combination product, biological, drug)

    Recruiting
    • Healthy Volunteers
    • Enteric Hyperoxaluria
    • NOV-001
    • +3 more
    • Birmingham, Alabama
    • +14 more
    Jun 24, 2022

    Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases Trial in Worldwide (DCR-PHXC)

    Enrolling by invitation
    • Primary Hyperoxaluria Type 1 (PH1)
    • +5 more
    • San Francisco, California
    • +19 more
    Jun 22, 2022

    Primary Hyperoxaluria Trial in Bonn (Oxalobacter formigenes)

    Completed
    • Primary Hyperoxaluria
    • Oxalobacter formigenes
    • Bonn, Germany
      Universitätsklinikum Bonn, Department of Paediatric Nephrology
    Dec 9, 2021

    Primary Hyperoxaluria Type 1 (PH1) Trial in Worldwide (Placebo, Lumasiran)

    Active, not recruiting
    • Primary Hyperoxaluria Type 1 (PH1)
    • San Diego, California
    • +15 more
    Mar 4, 2022

    Hyperoxaluria, Primary Trial in Worldwide (Oxabact OC5 - Oxalobacter formigenes Strain HC-1)

    Terminated
    • Hyperoxaluria, Primary
    • Oxabact OC5 - Oxalobacter formigenes Strain HC-1
    • Nashville, Tennessee
    • +7 more
    Nov 11, 2021

    Primary Hyperoxaluria, Primary Hyperoxaluria Type 1, Primary Hyperoxaluria Type 2 Trial in Worldwide (nedosiran)

    Not yet recruiting
    • Primary Hyperoxaluria
    • +2 more
    • (no location specified)
    Sep 8, 2021

    Primary Hyperoxaluria Trial in Worldwide (Oxabact OC5 - Oxalobacter formigenes HC-1, Placebo)

    Completed
    • Primary Hyperoxaluria
    • Oxabact OC5 - Oxalobacter formigenes HC-1
    • Placebo
    • Nashville, Tennessee
    • +9 more
    Dec 9, 2021

    Hyperoxaluria, Nonalcoholic Fatty Liver Disease, Kidney Stone Trial in United States (BMN 255, Placebo)

    Recruiting
    • Hyperoxaluria
    • +2 more
    • BMN 255
    • Placebo
    • Birmingham, Alabama
    • +6 more
    Nov 16, 2023

    Healthy, Enteric Hyperoxaluria Trial in United States (SYNB8802, Placebo)

    Recruiting
    • Healthy
    • Enteric Hyperoxaluria
    • Tucson, Arizona
    • +3 more
    May 11, 2021

    Hypercalciuria, Urolithiasis Trial (Radiological testing, Pediatric Urologic DNA and History Repository)

    Available
    • Hypercalciuria
    • Urolithiasis
    • Radiological testing
    • Pediatric Urologic DNA and History Repository
    • (no location specified)
    Aug 31, 2022

    PH1, Primary Hyperoxaluria, RNAi Therapeutic Trial in Worldwide (Lumasiran)

    Active, not recruiting
    • PH1
    • +4 more
    • Bordeaux, France
    • +8 more
    Jan 13, 2023

    Prospective Research Rare Kidney Stones (ProRKS)

    Recruiting
    • Hyperoxaluria
    • +4 more
      • Birmingham, Alabama
      • +10 more
      Nov 10, 2022

      Cystinosis, Primary Hyperoxaluria Trial in Hanover (Diagnostic test)

      Recruiting
      • Cystinosis
      • Primary Hyperoxaluria
      • Diagnostic test
      • Hanover, Lower Saxony, Germany
        Screening Laboratory Hanover
      Apr 24, 2023

      Healthy, Enteric Hyperoxaluria Trial in Cincinnati (FB-001, Placebo)

      Recruiting
      • Healthy
      • Enteric Hyperoxaluria
      • FB-001
      • Placebo
      • Cincinnati, Ohio
        Medpace Clinical Pharmacology Unit
      Jan 23, 2023

      Primary Hyperoxaluria Type 1 (PH1) Trial (Nedosiran)

      Available
      • Primary Hyperoxaluria Type 1 (PH1)
      • (no location specified)
      Aug 7, 2023

      Enteric Hyperoxaluria Trial in New York (Moderately High Oxalate (MOx) Diet)

      Recruiting
      • Enteric Hyperoxaluria
      • Moderately High Oxalate (MOx) Diet
      • New York, New York
        NYU Langone Health
      Nov 10, 2022

      Mortality of Rare Diseases in Taiwan With Real-world Evidence

      Completed
      • Rare Diseases
      • +5 more
      • longitudinal observational study
      • Tainan, Taiwan
        Department of Family Medicine, National Cheng Kung Univ Hosp
      May 9, 2022

      Bariatric Surgery Candidate, Kidney Stone Trial in Chicago (Special low-oxalate diet followed by all-day visit to University of

      Not yet recruiting
      • Bariatric Surgery Candidate
      • Kidney Stone
      • Special low-oxalate diet followed by all-day visit to University of Chicago research clinic
      • Chicago, Illinois
        University of Chicago Medical Center
      Apr 26, 2022

      Phenotyping of Primary Hyperoxaluria

      Recruiting
      • Primary Hyperoxaluria
        • Strasbourg, France
          Service de Néphrologie et Transplantation - Hôpitaux Universitai
        Oct 25, 2021

        Rare Kidney Stone Consortium Patient Registry

        Recruiting
        • Primary Hyperoxaluria
        • +3 more
          • Rochester, Minnesota
          • +3 more
          Aug 19, 2022

          Primary Hyperoxaluria Type 3 Trial in Worldwide

          Recruiting
          • Primary Hyperoxaluria Type 3
            • Boston, Massachusetts
            • +12 more
            Nov 16, 2021